The purpose of this interim DUR meeting is to finalize the clinical criteria for the products Exondys 51 and Spinraza.; May 3, 2017, 4:00 - 5:30 p.m.; AHCA, 2727 Mahan Dr., Bldg. 3, Conference Room D Tallahassee, FL 32308 1-888-670-3525; enter ...
AGENCY FOR HEALTH CARE ADMINISTRATION
The Florida Medicaid Drug Utilization Review Board announces a telephone conference call to which all persons are invited.
DATE AND TIME: May 3, 2017, 4:00 p.m. – 5:30 p.m.
PLACE: AHCA, 2727 Mahan Drive, Building 3, Conference Room D, Tallahassee, FL 32308, telephone conference dial: 1(888)670-3525, enter participant code: 4201652735 then #
GENERAL SUBJECT MATTER TO BE CONSIDERED: The purpose of this interim DUR meeting is to finalize the clinical criteria for the products Exondys 51 and Spinraza.
A copy of the agenda may be obtained by contacting: Vern.Hamilton@ahca.myflorida.com.
Document Information
- Hearing Meeting:
- AHCA, 2727 Mahan Dr., Bldg. 3, Conference Room D Tallahassee, FL 32308 1-888-670-3525; enter passcode 4201652735 then #
- Subject:
- The purpose of this interim DUR meeting is to finalize the clinical criteria for the products Exondys 51 and Spinraza.
- Meeting:
- telephone conference call
- Contact:
- Vern.Hamilton@ahca.myflorida.com